Cargando…

In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension

Detalles Bibliográficos
Autores principales:	Agarwal, Stuti, de Jesus Perez, Vinicio A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924564/ https://www.ncbi.nlm.nih.gov/pubmed/33095993 http://dx.doi.org/10.1164/rccm.202009-3706ED

Ejemplares similares

Recent advances in the management of pulmonary arterial hypertension
por: Tsai, Halley, et al.
Publicado: (2016)

Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension
por: Pienkos, Shaun, et al.
Publicado: (2021)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

Damaged DNA marching out of aging nucleus
por: Hacohen, Nir, et al.
Publicado: (2019)

DNA Damage and Repair in Pulmonary Arterial Hypertension
por: Sharma, Samantha, et al.
Publicado: (2020)

Hiding in Plain Sight: The Basement Membrane in Pulmonary Vascular Remodeling
por: Chakraborty, Ananya, et al.
Publicado: (2020)

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection
por: Zamanian, Roham T., et al.
Publicado: (2020)

Sugen–morphine model of pulmonary arterial hypertension
por: Agarwal, Stuti, et al.
Publicado: (2020)

CAG RNAs induce DNA damage and apoptosis by silencing NUDT16 expression in polyglutamine degeneration
por: Peng, Shaohong, et al.
Publicado: (2021)

Loss of Nudt15 thiopurine detoxification increases direct DNA damage in hematopoietic stem cells
por: Yamashita, Noriaki, et al.
Publicado: (2023)

Low-grade albuminuria in pulmonary arterial hypertension
por: Nickel, Nils P., et al.
Publicado: (2019)

Emerging Pathogenetic Mechanisms of Pulmonary Arterial Hypertension: Nitric Oxide and More
por: Kim, Young Dae
Publicado: (2011)

The DNA Damage Response and HIV-Associated Pulmonary Arterial Hypertension
por: Simenauer, Ari, et al.
Publicado: (2020)

The social and economic disadvantage in pulmonary hypertension: A work (still) in progress
por: Bernardo, Roberto J., et al.
Publicado: (2023)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

Myocardial bridge: an unrecognized cause of chest pain in pulmonary arterial hypertension
por: Rajmohan, Divya, et al.
Publicado: (2020)

DNA Damage and Pulmonary Hypertension
por: Ranchoux, Benoît, et al.
Publicado: (2016)

Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction
por: Perez, Vinicio A. de Jesus, et al.
Publicado: (2012)

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
por: Tang, Haiyang, et al.
Publicado: (2017)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Editorial: Pulmonary Hypertension in the Modern Era: Science and Clinical Practice
por: Goncharova, Elena A., et al.
Publicado: (2021)

Differential Modulation of Markers of Oxidative Stress and DNA Damage in Arterial Hypertension
por: Kreutzmann, Moritz, et al.
Publicado: (2023)

Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)
por: Ranchoux, Benoît, et al.
Publicado: (2017)

Complex interplay of DNA damage, DNA repair genes, and oxidative stress in coronary artery disease
por: Vakonaki, Elena, et al.
Publicado: (2016)

Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension
por: Isobe, Sarasa, et al.
Publicado: (2023)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

Editorial: Pulmonary hypertension in the modern era: Science and clinical practice, Volume II
por: Bogaard, Harm J., et al.
Publicado: (2023)

Role of the NUDT Enzymes in Breast Cancer
por: Wright, Roni H. G., et al.
Publicado: (2021)

DNA Damage and Oxidative Stress in Human Disease
por: Maluf, Sharbel Weidner, et al.
Publicado: (2013)

Targeted proteomics of right heart adaptation to pulmonary arterial hypertension
por: Amsallem, Myriam, et al.
Publicado: (2021)

Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

Pulmonary arterial hypertension in adults with atrial septal defect
por: Toyono, Manatomo
Publicado: (2012)

A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension
por: Grinnan, Daniel, et al.
Publicado: (2019)

Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sfkjkgqchlpgiftnl52jc6hi05